Antineoplastic Agent, Antiandrogen
CSA NA – FDA Approved – REMS (N) – Can Ship
How Does It Work
Darolutamide, Nubeqa is a competitive androgen receptor inhibitor that inhibits androgen binding, AR nuclear translocation, and AR-mediated transcription. Darolutamide, Nubeqa has been shown to decrease prostate cancer cell proliferation.
Indications For Use
Before starting Darolutamide, Nubeqa makes sure your physician is aware of any allergies or medications you currently take. Darolutamide, Nubeqa can cause bone marrow suppression and should be used with caution in patients who have cardiovascular disease, hepatic and/or renal impairment.
Oral: 600mg twice daily.
Missed dose: If a dose is missed, administer as soon as possible prior to the next scheduled dose; do not take 2 doses at the same time to make up for a missed dose.
Pharmacist Tips On Using
How to Take: Take with food; swallow whole and do not crush, chew or split the tablet.
Fatigue, neutropenia, elevated liver enzymes, asthenia.
Note this is not a complete list of side effects for Darolutamide, Nubeqa only common ones.
Frequently Asked Questions
Why would my physician prescribe a medication with such serious side effects?
Your physician takes the most recent clinical guidelines to make evidence-based decisions on what medication is appropriate in which situations. Your current medications, your allergies, age, cost of medication, comorbid conditions, and many other factors will further complicate or limit which medications are appropriate. This medication is used for certain forms of cancer and your physician has determined the benefits outweigh the risks. Furthermore, they will be monitoring your bloodwork and symptoms closely to avoid many of the serious side effects and will keep you on the lowest effective dosage for the shortest amount of time possible.